Stroke 2008 - Preliminary Scientific Program: Thursday

PRELIMINARY SCIENTIFIC PROGRAM

Thursday, September 25, 2008
07:30-08:30	Free Communications Sessions Clinical Phenomenology Right-Hemispheric Stroke Is Associated With Impaired Cardiac Baroreceptor Sensitivity Nainal Shah, UK Intensive Medical Therapy Has Reduced Tcd Microemboli And Cardiovascular Events In Asymptomatic Carotid Stenosis J. David Spence, Canada Stent-Pta For Symptomatic Vertebrobasilar Artery Stenosis Thomas Seifert, Austria Incidence Of Atrial Fibrillation After Percutaneous Closure Of Patent Foramen Ovale In Patients Presenting With Cryptogenic Stroke: A Case-Control Study Robert Bonvini, Switzerland Population-Based Study Of The Frequency Of >=50% Symptomatic Stenosis In Vertebrobasilar TIA Or Minor Stroke Lars Marquardt, UK Single Seizure And Epilepsy In Patients With A Cerebral Territorial Infarct Jacques De Reuck, Belgium Hemorrhage Cerebral Microbleeds: Clinical And Imaging Follow Up Yn Huang, China White Matter Lesions Increase Hemorrhage Volume And Mortality Rate In Patients With Intracerebral Hemorrhage: The Acute Brain Bleeding Analysis Seung-Hoon Lee, South Korea Imaging Characteristics In Thrombotic Thrombocytopenic Purpura Tamika Burros, USA Down-Regulation Of Tight Junction Proteins Triggers And Promotes Cerebral Aneurysms Formation In Rats Yoshiteru Tada, Japan Long-Term Risk Of Hemorrhage In Unruptured Intracranial Aneurysms Robert Brown, USA Imaging: CT or MRI Functional MRI Evidence For Changes In Sensorimotor Control Subsequent To A Novel Robotic-Assisted Hand Rehabilitation Programme After Stroke Christian Enzinger, Austria High-Resolution CT Imaging Of Carotid Artery Atherosclerotic Plaques Max Wintermark, USA Clinical-Diffusion Mismatch May Predict Good Clinical Outcome In Acute Stroke Patients Treated With Intravenous Thrombolysis Daniel Sanak, Czech Republic Clinical-Diffusion Mismatch And Benefit From Thrombolysis 3-6 Hours After Acute Stroke Martin Ebinger, Australia Imaging Early Corticospinal Tract Wallerian Degeneration To Predict Acute Stroke Outcome Giselle DeVetten, Canada Hypoperfusion Measurement By MRI In Early Stroke: A Comparison With 15o-Water Pet In 24 Patients Jan Sobesky, Germany Imaging: Other Modalities Carotid Duplex Ultrasonography Can Predict Efficacy And Safety Of Intravenous T-PA Therapy For Hyperacute Stroke Masatoshi Koga, Japan Biological Effect Of A 1-Hour Lasting Sono-Thrombotripsy Using A Diagnostic 2-4 Mhz Transcranial Probe David Skoloudik, Czech Republic Impact Of Carotid Atherosclerosis On Stroke Risk After A Transient Ischemic Attack In SOS-TIA Philippa Lavallee, France Clinical And Pathophysiological Differences Between Migrainous Stroke And Migraine With Persistent Aura: An MR-Spectroscopy Study Ursula Schulz, UK Retinal Arteriol Branching Co-Efficients Are Associated With White Matter Lesions And Ischaemic Heart Disease But Not Stroke Subtypes Rosemarie De Haan, The Netherlands Retinal Vessel Diameters Differ In Ischaemic Stroke Subtypes Fergus Neil Doubal, UK Acute Management I Efficacy Of Pre-Hospital Diagnosis And Triage Of Acute Stroke Henri Van De Wetering, The Netherlands Long-Term Effects Of Specialised Stroke Care With Telemedical Support In Community Hospitals; The Telemedical Project For Integrative Stroke Care (Tempis) Heinrich, J Audebert, UK Use Of Biomarkers In Triage Of Patients With Suspected Stroke Simone Vanni, Italy Partial aortic obstruction improves cerebral perfusion in patients with symptomatic vasospasm. Mid term follow-up Pedro Lylyk, Argentina The Effect Of Physiologic Derangement In Stroke Patients Treated With Thrombolysis Titto Idicula, Norway Impact Of Baseline Arterial Obstruction Site And Degree On Outcomes In The Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Deidre De Silva, Singapore
08:30-10:00	Main Theme 1 Acute Interventions in Acute Ischemic Stroke Part 1: Devices Convenors: Wade S. Smith, USA Pierre Gobin, USA The MERCI Experience Wade S. Smith, USA The World of Embolectomy Devices Pierre Gobin, USA Stenting and Angioplasty Randall T. Higashida, USA
	Main Theme 2 Stroke Prevention Intracranial Atherosclerosis Convenors: Jong S. Kim, South Korea Marc L. Chimowitz, USA Risk Factors and Ethnic Differences Ka Sing Lawrence Wong, China Stroke Mechanism and Clinical Syndromes Jong S. Kim, South Korea Treatment: Medicine vs. Stenting Marc L. Chimowitz, USA Natural Course and Prognosis Juan F. Arenillas, Spain Intracranial Atherosclerosis - conservative management Michael Knoflach, Austria
	Main Theme 3 Hemorrhagic Stroke Subarachnoid Hemorrhage – State of the Art Convenors: Andrew Molyneux, UK Jose I. Suarez, USA Progress in Unravelling the Pathophysiology of Vasospasm To be Advised Insights into the Basis of Aneurysm Formation, Rupture and Cerebral Vasospasm Martin M. Brown, UK Update on Neuromonitoring in Subarachnoid Hemorrhage Andreas Unterberg, Germany Clinical Trial Design in Subarachnoid Hemorrhage Gabriel Rinkel, The Netherlands
	Main Theme 4 Clinical Trials Hot Topics in Clinical Trial Design Convenors: Marc Fisher, USA Stephen M. Davis, Australia Proportional Shift Analysis Should Frequently Replace Traditional Dichotomy Jeffrey L. Saver, USA Biological Proof of Principle is an Essential Prelude to Phase 3 Trials Steven Warach, USA Fixed Sample Size is Preferable to Adaptive Design George Howard, USA Is Penumbral Selection Now the Gold Standard for Acute Stroke Trials? Wolfgang Soehngen, Germany
	Main Theme 5 Basic Science Brain Repair and Recovery Convenors: Michael Chopp, USA Olle Lindvall, Sweden Neurogenesis Olle Lindvall, Sweden Brain Plasticity - Synaptic Reorganization after Stroke Randolph J. Nudo, USA Restorative Therapies for Stroke Michael Chopp, USA
10:00-10:30	Coffee Break
10:30-12:00	Presidential Symposium Reducing the Global Burden of Stroke Convenors: Geoffrey Donnan, Australia Michael Brainin, Austria What Are the Most Important Issues Facing Stroke Physicians Globally? Geoffrey A. Donnan, Australia How Can Cardiologists and Stroke Physicians Work Together to Reduce the Burden of Vascular Disease? Pekka Puska, Finland What will Happen if we don’t Address the Problem of Stroke on a Global Level? Ruth Bonita, New Zealand What are the Most Effective Tools to Reduce Stroke in Developed Countries? Michael Brainin, Austria How Should we Address the Problem of Stroke in Developing Countries Vivian Fritz, South Africa
12:30-14:00	Satellite Symposia / Lunch Break ESO / WSC Lunch Symposium: Controversies in Stroke Management Supported by an Unrestricted Educational Grant from Boehringer Ingelheim Convenors: Geoffrey Donnan, Australia Michael Brainin, Austria Will the PRoFESS Results Change the International Guidelines? Ralph Sacco, USA and Didier Leys, France When Do We need MRI Imaging for Thrombolysis? Rudiger von Kummer, Germany and Steven Davis, Australia Recanalization: Devices or Medical Therapy? Pierre Gobin, USA and Werner Hacke, Germany Otsuka Sponsored Symposium - New Approaches for Ischemic Brain Infarcts Convenors: Yukito Shinohara, Japan Michael M. Hennerici, Germany Cilostazol, Adenosine, and Protection in Ischemia/Reperfusion Injury Y. Liu, USA Effects of Cilostazol in Patients with Intracranial and Extracranial Atherothrombotic Diseases S. Uchiyama, Japan Cilostazol as a Guardian Against Ischemic Microvascular Damages M. Suematsu, Japan Antithrombotic Therapy in Acute Ischemic Stroke Yong-Seok Lee, South Korea Ebewe Sponsored Symposium Convenors: Michael Brainin, Austria Wolf-Dieter Heiss, Germany Cerebral Reorganisation after Stroke Rüdiger Seitz, Germany Continuity between neuroprotection, neuroplasticity and brain recovery Dafin Muresanu, Romania Recovery drugs and study endpoints Natan Bornstein, Israel A neurotrophic treatment option supports stroke recovery Christian Stadler, Germany
14:00-15:30	Plenary I The WSO-WHF Symposium: Heart Meets Brain Convenors: Geoffrey A. Donnan, Australia Pekka Puska, Finland Intervention in Myocardial Ischaemia: Techniques and Time Windows TBA Interventions for Cerebral Ischaemia: Techniques and Time Windows Randall Higashida, USA Atrial fibrillation: Recent Advances and Future Directions from a Stroke Perspective Claudia Stoellberger, Austria Atrial Fibrillation: Recent Advances and Future Directions from a Cardiologists Perspective Paulus Kirchhof, Germany Roundtable Discussion
15:30-16:00	Coffee Break
16:00-17:30	Main Theme 6 Acute Interventions in Acute Ischemic Stroke Part 2: Medical Convenors: Gregory W. Albers, USA Kennedy Lees, UK Delivering iv rt-PA Routinely with Limited Resources David Hess, USA Moving Beyond iv rt-PA: DIAS Kennedy Lees, UK Assessing the Effect of Interventions for Acute Ischemic Stroke Matthew R. Walters, UK Keeping Neuroprotection Alive Until We can Protect the Brain Stephen M. Davis, Australia Maintaining Cerebral Perfusion and Other Non-Pharmacological Approaches Peter D. Schellinger, Germany
	Main Theme 7 Stroke Prevention Diabetes, Hypertension and Stroke Convenors: Natan M. Bornstein, Israel Brett M. Kissela, USA Diabetes and Hypertension as Risk Factors for Various Sub-Type of Stroke Ralph L. Sacco, USA Insulin Resistance, Metabolic Syndrome and Stroke Walter Kernan, USA Primary and Secondary Prevention of Stroke - Is Aggressive Blood Pressure Reduction Important? Jan A. Staessen, Belgium Changes in Blood Pressure in Sleep and Sleep Apnea Antonio Culebras, USA Stroke Incidence in Type I and Type II Diabetes Brett M. Kissela, USA Management of Hyperglycemia in Acute Ischemic Stroke Natan M. Bornstein, Israel
	Main Theme 8 Advances in Diagnostic and Therapeutic Ultrasound Convenors: Stephen Meairs, Germany Raymond T.F. Cheung, China Advances in Treating Stroke Patients with Ultrasound and Microbubbles Carlos Molina, Spain The Role of Ultrasound Perfusion Imaging in the Management of Stroke Günter Seidel, Germany Targeting Thrombolysis with Ultrasound-Sensitive Liposomes Christy K. Holland, USA Ultrasound and the Neurovascular Unit - from Drug Delivery to Angiogenesis Stephen Meairs, Germany
	Main Theme 9 Stroke Services Organized Stroke Care: A Cost Effective Approach Convenors: Didier Leys, France Mark J. Alberts, USA What is Evidence-Based in Organized Stroke Care? Laszlo Csiba, Hungary What Should be the Main Components of Organized Stroke Care? Erich Bernd Ringelstein, Germany The Place of Telemedicine in Stroke Care Robert J. Adams, USA What Facilities are Available for Stroke Patients in European Hospitals? Didier Leys, France How to Organize Stroke Care in Emerging Countries? Nijasri C. Suwanwela, Thailand
	Main Theme 10 Stroke and Immunology Convenors: Michael A. Moskowitz, USA John M. Hallenbeck, USA Immune Mechanisms in Tolerance to Ischemia Mary Stenzel-Poore, USA Lymphocytes in CNS after Ischemia - Injury & Cytoprotection Kyra Becker, USA Post-CNS Injury Immunodepression Angel Chamorro, Spain Immunization/Tolerization in Stroke (Atherosclerosis, Stroke Prevention, Ischemia Cytoprotection, Vascular Cognitive Impairment, Adult Neurogenesis) John M. Hallenbeck, USA
16:00-17:30	Neuropsychological Rehabilitation Convenors: Randolph Marshall, USA Georg Goldenberg, Germany Clinical Assessment and Treatment Options Wilfred Lang, Austria Aphasia Randolph Marshall, USA Apraxia Georg Goldenberg, Germany Behavioural Disorders Following Stroke Jose Ferro, Portugal
17:45-18:45	Otsuka Satellite Symposia
	Virchow's Triads 2008 -The Next Target for Antithrombotic Therapy Convenors: Louis R. Caplan, USA Takenori Yamaguchi, Japan Vascular Targets for Treatment in Evolving Cerebral Ischemia and Virchow‘s Triad G.J. del Zoppo, USA Cilostazol as a guardian against ischemic microvascular damages M. Suematsu, Japan TBA L.R. Caplan, USA

PRELIMINARY SCIENTIFIC PROGRAM

Thursday, September 25, 2008